Neuropharmacology of synaptic plasticity: pathways to cognitive resilience in healthy aging.
Study Design
- Study Type
- Review
- Population
- aging individuals with cognitive decline
- Intervention
- Neuropharmacology of synaptic plasticity: pathways to cognitive resilience in healthy aging. None
- Comparator
- None
- Primary Outcome
- None
- Effect Direction
- Positive
- Risk of Bias
- Unclear
Abstract
The aging process is associated with gradual cognitive decline resulting from deficits in synaptic plasticity, the brain's natural ability to adapt and reshape its neural circuitry. This review highlights the importance of synaptic plasticity in cognitive function. It provides a full overview of the molecular, cellular, and systemic mechanisms involved in enhanced or diminished synaptic plasticity in the aging brain. We also go over issues in neurotransmitter systems, calcium signaling, neurotrophic support (ex., BDNF-TrkB), cellular signaling pathways (e.g. mTOR, CaMK, CREB, and MAPK/ERK), and neuroinflammation, oxidative stress, and vascular integrity, all of which redirect the trajectory of synaptic failure associated with cognitive decline in aging. Therapeutic approaches toward increasing or restoring synaptic plasticity are evaluated, including pharmacological (e.g., nootropics, cholinesterase inhibitors, NMDA receptor modulators), natural (e.g., curcumin, resveratrol, bacoside A), and new interventions (e.g., psychoplastogens, gene therapy, nanocarriers, and digital therapeutics). Lifestyle approaches, especially physical exercise, cognitive training, intermittent fasting, and mindfulness approaches to stimulation, have highly potent effects on plasticity enhancements and employ multiple neurobiological mechanisms. Despite much promise, there remain substantial translational challenges, including limited clinical efficacy, lack of personalized biomarkers, and ethical considerations concerning cognitive enhancement. As we look ahead, a multidisciplinary integrative approach that includes molecular therapeutics, lifestyle interventions, and next-generation neurotechnologies will be most useful for protecting cognitive health and enhancing brain resilience in aging individuals. This review highlights the immediate necessity for personalized, ethical, and evidence-based approaches to take advantage of synaptic plasticity for healthy cognitive aging.
TL;DR
A multidisciplinary integrative approach that includes molecular therapeutics, lifestyle interventions, and next-generation neurotechnologies will be most useful for protecting cognitive health and enhancing brain resilience in aging individuals.
Used In Evidence Reviews
Similar Papers
Journal of neuroinflammation · 2019
Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway.
Molecular immunology · 2019
Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/ TLR4/ NF-κB pathways in BV2 cells.
Journal of Alzheimer's disease : JAD · 2018
Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.
Neurotoxicity research · 2013
Neuroinflammation, neurodegeneration, and depression.
Advances in nutrition (Bethesda, Md.) · 2017
Nutritional Factors Affecting Adult Neurogenesis and Cognitive Function.
The Proceedings of the Nutrition Society · 2002